Do single enantiomers have something special to offer?
- 4 December 2001
- journal article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 16 (S2) , S67-S71
- https://doi.org/10.1002/hup.339
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Development of chiral drugs in Japan: An update on regulatory and industrial opinionChirality, 1995
- Absolute configurations and conformations of the opioid agonist and antagonist enantiomers of picenadolChirality, 1995
- Angiotensin II receptor antagonists. From discovery to antihypertensive drugs.Hypertension, 1991
- Regulatory aspects of the development of chiral drugs in Japan: A status reportChirality, 1991
- Comparative effects of the diastereoisomers, quinine and quinidine in producing phenocopy debrisoquine poor metabolisers (PMs) in healthy volunteersChirality, 1991
- Basic mechanisms underlying prenylamine-induced ‘torsade de pointes’: differences between prenylamine and fendiline due to basic actions of the isomersCurrent Medical Research and Opinion, 1988
- Stereoselective Effects of Disopyramide Enantiomers in HumansJournal of Cardiovascular Pharmacology, 1987
- The Importance of Stereochemistry in the Clinical Pharmacokinetics of the 2-Arylpropionic Acid Non-Steroidal Anti-Inflammatory DrugsClinical Pharmacokinetics, 1984
- The metabolic chiral inversion of 2-arylpropionic acids—a novel route with pharmacological consequencesJournal of Pharmacy and Pharmacology, 1983
- The cardiac effects of d- and l-disopyramide in normal subjects: a noninvasive study.Circulation, 1982